New drugs cost an average of $180K per year, new study finds
fotografixx/E+ via Getty Images


The median price of a new drug launched in 2021 was $180K per year, according to a new study.
The highest priced new drugs were for rare diseases (median $263.7K) and oncology (median $155.1K).
Researchers from Brigham and Women's Hospital wrote in JAMA that unadjusted mean launch prices have surged 20% per year since 2008. In that year, the average new drug launched was $2115.

They also found that more than 47% of new drugs introduced in 2020 and 2021 were priced at more than $150K per year.
Major pharma and biotech companies: Pfizer (NYSE:PFE), Merck (NYSE:MRK), Lilly (Lilly), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), GlaxoSmithKline (GSK), Roche (OTCQX:RHHBY), Amgen (AMGN), AbbVie (NYSE:ABBV), Gilead (NASDAQ:GILD).
U.S. drugmakers raised the list prices of many drugs early in 2022.